Cybin (HELP) Receivables - Net (2021 - 2025)

Cybin (HELP) reported Receivables - Net of $4.1 million for Q1 2025, up 23.47% on a YoY basis from $3.3 million in Q1 2024, and up 23.47% quarter-over-quarter from $3.3 million in Q1 2024.

Cybin (HELP) Receivables - Net (2021 - 2025) Analysis & Trends

Cybin has reported Receivables - Net for 3 years, with the latest figure at $4.1 million in Q1 2025.

  • For the quarter ending Q1 2025, Receivables - Net rose 23.47% year-over-year to $4.1 million; the trailing twelve-month figure through Mar 2025 stood at $4.1 million (up 23.47% YoY), and the FY2025 full-year result was $4.2 million, up 27.45% from the prior year.
  • Receivables - Net for Q1 2025 stood at $4.1 million, up from $3.3 million in the prior quarter.
  • The five-year high for Receivables - Net was $4.1 million in Q1 2025, with the low at $1.1 million in Q1 2021.
  • Historically, Receivables - Net has averaged $2.8 million across 3 years, with a median of $3.3 million in 2024.
  • The largest YoY upside for Receivables - Net was 23.47% in 2025 against a maximum downside of 23.47% in 2025.
  • Cybin's Receivables - Net stood at $1.1 million in 2021, then surged by 216.34% to $3.3 million in 2024, then increased by 23.47% to $4.1 million in 2025.
  • The last three Receivables - Net figures came in at $4.1 million (Q1 2025), $3.3 million (Q1 2024), and $1.1 million (Q1 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Cybin 75.42 Mn 75.42 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 4.10 Mn
Mar 31, 2025 4.10 Mn
Mar 31, 2024 3.32 Mn
Mar 31, 2024 3.32 Mn
Mar 31, 2021 1.05 Mn
Mar 31, 2021 1.05 Mn